The U.S. Food and Drug Administration (FDA) approved a new sunscreen ingredient for American consumers. This event might seem routine, but it is notable since the last time the FDA authorized such an ingredient was in 1999. The delay traces back to an antiquated law enacted 88 years ago.

Despite modern scientific advancements, the U.S. market has lagged in sunscreen innovation, preventing access to more effective products. This stagnation has persisted because of the legislation dating back to 1938. It has hindered the entry of new and improved sunscreens that other countries have used for years.

The outdated legal framework has not only affected consumers but also the sunscreen industry in the United States. This delay in adopting new technology has had consequences for skin health, as better formulations remain inaccessible.

Bringing attention to this regulatory issue can help foster updates to these laws. Doing so would facilitate the introduction of state-of-the-art sunscreen products, benefiting public health across the country.

For nearly nine decades, the 1938 law has slowed progress in this area. The recent approval marks a small step forward. It highlights the need for ongoing revisions to allow Americans better access to medical and cosmetic advancements.